Home >News >India >Covid-19: Fresh guidelines for blood transfusion services

New Delhi: In order to maintain a safe and adequate blood supply during the COVID-19 pandemic, the Union Health Ministry has issued revised guidance for blood transfusion services in India. Taking inputs from the World Health Organisation (WHO) interim guidance, the Health Ministry has updated the national guidance for blood transfusion services.

Dr Sunil Gupta, additional director general, Blood Transfusion Services at NACO has requested all the State AIDS Control Societies and State Blood Transfusion Councils to adopt the guidelines to their specific needs. Dr Gupta has directed the professionals engaged in blood transfusion services to facilitate the maintenance of adequate stocks of safe blood to meet requirements.

Speaking to ANI, Dr Gupta said: "We have reworked upon several factors. It includes--(i) criteria for post-donation care, (ii) recommendation on testing of blood and blood components for COVID-19 pathogen reduction technologies etc, (iii) managing the supply chain system for commodities required in blood transfusion services, (iv) collection of convalescent plasma, (v) managing the supply chain system for commodities required in the blood transfusion service."

Here are 5 things to know about fresh guidelines for blood transfusion services:

1) While revising the existing national guidance for blood transfusion service, the National Blood Transfusion Councils (NTBC) has updated the exclusion criteria for donors to maintain blood safety, infection control measures etc.

2) Use of facemask by healthcare providers in blood centre, blood mobile van or an outdoor blood donation camp shall be mandatory to prevent transmission of the virus.

3) "For the collection of convalescent plasma and the clinical trials from cured COVID-19 patients, the donor selection criteria specifically for this purpose should be as per the Drug Controller General of India (DCGI)," read the guidelines.

4) The guidelines further stated that the use of convalescent plasma for routine COVID-19 treatment of COVID-19 patient is not recommended at present.

5) The latest guidance of safe blood transfusion service is in the suppression of the first guidance issued by NBTC on March 25.

Subscribe to newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperLivemint.com is now on Telegram. Join Livemint channel in your Telegram and stay updated

My Reads Logout